{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:52:40Z","timestamp":1793253160482,"version":"4.5.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Serum uric acid (UA) levels may be involved in the development of myasthenia gravis (MG) by inhibiting oxidative stress, but the relationship remains unclear. This meta-analysis aimed to assess the association between serum UA levels and MG patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      According to the established protocol, researchers searched 9 databases for studies on UA levels in MG patients, assessed using the Newcastle\u2013Ottawa Scale. Heterogeneity was evaluated with the\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      statistic and chi-square test. Publication bias was analyzed using funnel plots and Egger test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      This meta-analysis included 9 case-control studies from China, with 2112 participants (955 MG patients, 1157 healthy controls). All studies had Newcastle\u2013Ottawa Scale quality scores of 7 or above. Results showed significantly lower serum UA levels in MG patients compared to controls (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u200558%, mean difference [MD]: \u221243.86, 95% confidence interval [CI]: [\u201054.98, \u221232.74],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001). Age differences were identified as a source of heterogeneity, confirmed by subgroup analysis. Subgroup analyses showed that in age-comparable groups, MG and healthy controls had lower heterogeneity in UA levels (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u200518%, MD: \u221236.57, 95% CI: [\u201044.62, \u221228.50],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001), and in age-disparate groups (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u20050%, MD: \u221273.78, 95% CI: [\u201094.13, \u221253.44],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001). Gender analyses showed UA levels in men (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u200569%, MD: \u221260.29, 95% CI: [\u201081.75, \u221238.83],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001) and women (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u20051%, MD: \u221229.80, 95% CI: [\u201038.03, \u221221.57],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Lower serum levels of UA are associated with an increased risk of MG, although further large-scale, well-controlled studies are needed to confirm the potential clinical relevance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045364","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:01:52Z","timestamp":1762210912000},"page":"e45364","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Association between serum uric acid levels and myasthenia gravis: A meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Lang","family":"Liu","sequence":"first","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yang","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingli","family":"Sun","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2636-7367","authenticated-orcid":false,"given":"Jiangqin","family":"Ou","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1007\/s00415-024-12714-5","article-title":"Treatment of myasthenia gravis in france: a retrospective claims database study (STAMINA).","volume":"271","author":"Tard","year":"2024","journal-title":"J Neurol"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the guidelines of the German Neurological Society.","volume":"263","author":"Melzer","year":"2016","journal-title":"J Neurol"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations.","volume":"10","author":"Dresser","year":"2021","journal-title":"J Clin Med"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000529583","article-title":"Incidence, prevalence, hospitalization rates, and treatment patterns in myasthenia gravis: a 10-year real-world data analysis of German Claims data.","volume":"57","author":"Wartmann","year":"2023","journal-title":"Neuroepidemiology"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders.","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1475-2891-7-29","article-title":"The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk\/benefit profile.","volume":"7","author":"Brambilla","year":"2008","journal-title":"Nutr J"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clineuro.2018.03.023","article-title":"Association between serum uric acid level and multiple system atrophy: a meta-analysis.","volume":"169","author":"Zhang","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1515\/cclm-2014-0744","article-title":"Uric acid: a potential biomarker of multiple sclerosis and of its disability.","volume":"53","author":"Moccia","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"e0173731","DOI":"10.1371\/journal.pone.0173731","article-title":"Serum uric acid levels in patients with Parkinson\u2019s disease: a meta-analysis.","volume":"12","author":"Wen","year":"2017","journal-title":"PLoS One"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"e8497","DOI":"10.1136\/bmj.e8497","article-title":"Myasthenia gravis.","volume":"345","author":"Spillane","year":"2012","journal-title":"BMJ"},{"key":"R11-20260915","first-page":"934","article-title":"Chinese guidelines for the diagnosis and treatment of myasthenia gravis 2015.","volume":"48","year":"2015","journal-title":"Chin J Neurol"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R14-20260915","first-page":"939","article-title":"Clinical value of changes of serumbil and UA levels inpatients with myastheniagravis.","volume":"13","author":"Huang","year":"2015","journal-title":"Chin J General Pract"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1080\/00207454.2020.1759592","article-title":"The correlation of neutrophil-to-lymphocyte ratio with the presence and short-time curative effect of myasthenia gravis in children: a retrospectively study.","volume":"131","author":"Jiang","year":"2021","journal-title":"Int J Neurosci"},{"key":"R16-20260915","first-page":"6857","article-title":"Effect of serum levels of BIL and UA in myastheniavgravis patients.","volume":"15","author":"Jing","year":"2015","journal-title":"Progress Modern Bio Med"},{"key":"R17-20260915","first-page":"1","article-title":"Clinical analysis of changes in serum uric acid, bilirubin and albumin levels in patients with myasthenia gravis.","volume":"2","author":"Liu","year":"2022","journal-title":"Guizhou Med Univ"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1352458507082143","article-title":"Serum uric acid levels of patients with multiple sclerosis and other neurological diseases.","volume":"14","author":"Peng","year":"2008","journal-title":"Mult Scler"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000327727","article-title":"Antioxidant status of bilirubin and uric acid in patients with myasthenia gravis.","volume":"19","author":"Fuhua","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3109\/00207454.2015.1134526","article-title":"Low antioxidant status of serum bilirubin, uric acid, albumin and creatinine in patients with myasthenia gravis.","volume":"126","author":"Yang","year":"2016","journal-title":"Int J Neurosci"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/WNR.0000000000000535","article-title":"Serum uric acid levels in patients with myasthenia gravis are inversely correlated with disability.","volume":"27","author":"Yang","year":"2016","journal-title":"Neuroreport"},{"key":"R22-20260915","first-page":"1287","article-title":"Changes of serum bilirubin and uric acid in patients with myasthenia gravis.","volume":"93","author":"Zhou","year":"2013","journal-title":"Natl Med J China"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"1065739","DOI":"10.3389\/fimmu.2022.1065739","article-title":"Associations between serum urate and telomere length and inflammation markers: evidence from UK Biobank cohort.","volume":"13","author":"Lv","year":"2022","journal-title":"Front Immunol"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.bcp.2015.07.011","article-title":"AChR-specific immunosuppressive therapy of myasthenia gravis.","volume":"97","author":"Luo","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"e70361","DOI":"10.1111\/cns.70361","article-title":"Comprehensive analysis of uric acid and myasthenia gravis: IGF1R as a protective factor and potential therapeutic target.","volume":"31","author":"Shen","year":"2025","journal-title":"CNS Neurosci Ther"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease.","volume":"39","author":"Valko","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.freeradbiomed.2022.08.004","article-title":"Dual effects of supplemental oxygen on pulmonary infection, inflammatory lung injury, and neuromodulation in aging and COVID-19.","volume":"190","author":"Lin","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"13315","DOI":"10.3390\/ijms222413315","article-title":"Crosstalk between neuron and glial cells in oxidative injury and neuroprotection.","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"102594","DOI":"10.1016\/j.redox.2022.102594","article-title":"Diminished \u03b17 nicotinic acetylcholine receptor (\u03b17nAChR) rescues amyloid-\u03b2 induced atrial remodeling by oxi-CaMKII\/MAPK\/AP-1 axis-mediated mitochondrial oxidative stress.","volume":"59","author":"Zhao","year":"2023","journal-title":"Redox Biol"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.freeradbiomed.2020.05.017","article-title":"Cadmium desynchronizes neurotransmitter release in the neuromuscular junction: key role of ROS.","volume":"155","author":"Tsentsevitsky","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-\u03baB signaling.","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","article-title":"The diversified role of mitochondria in ferroptosis in cancer.","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function.","volume":"82","author":"Dr\u00f6ge","year":"2002","journal-title":"Physiol Rev"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"H1009","DOI":"10.1152\/ajpheart.00438.2006","article-title":"Oxidative stress of myosin contributes to skeletal muscle dysfunction in rats with chronic heart failure.","volume":"292","author":"Coirault","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/j.2040-4603.2011.tb00348.x","article-title":"Reactive oxygen species: impact on skeletal muscle.","volume":"1","author":"Powers","year":"2011","journal-title":"Compr Physiol"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1471-4159.2009.06040.x","article-title":"Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization.","volume":"109","author":"Guerreiro","year":"2009","journal-title":"J Neurochem"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/metabo13070787","article-title":"Inborn errors of purine salvage and catabolism.","volume":"13","author":"Camici","year":"2023","journal-title":"Metabolites"},{"key":"R38-20260915","first-page":"1321","article-title":"Enzymes involved in purine metabolism \u2013 a review of histochemical localization and functional implications.","volume":"14","author":"Moriwaki","year":"1999","journal-title":"Histol Histopathol"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1080\/13880209.2016.1195847","article-title":"Uric acid transporters hiding in the intestine.","volume":"54","author":"Xu","year":"2016","journal-title":"Pharm Biol"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis.","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu Rev Physiol"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","article-title":"New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.","volume":"319","author":"Furuhashi","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"102271","DOI":"10.1016\/j.redox.2022.102271","article-title":"U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia.","volume":"51","author":"Crawley","year":"2022","journal-title":"Redox Biol"},{"key":"R43-20260915","doi-asserted-by":"crossref","first-page":"156843","DOI":"10.1016\/j.cyto.2024.156843","article-title":"Exploring the causal relationship between inflammatory cytokines and myasthenia gravis: a two-way Mendelian randomization study.","volume":"186","author":"Li","year":"2025","journal-title":"Cytokine"},{"key":"R44-20260915","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jgr.2020.08.005","article-title":"Saponins from Panax japonicus ameliorate age-related renal fibrosis by inhibition of inflammation mediated by NF-\u03baB and TGF-\u03b21\/Smad signaling and suppression of oxidative stress via activation of Nrf2-ARE signaling.","volume":"45","author":"Gao","year":"2021","journal-title":"J Ginseng Res"},{"key":"R45-20260915","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis.","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"R46-20260915","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1007\/s12035-025-04744-5","article-title":"Serum inflammatory factors levels and risk of myasthenia gravis: a bidirectional mendelian randomization study.","volume":"62","author":"Jingjing","year":"2025","journal-title":"Mol Neurobiol"},{"key":"R47-20260915","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment.","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:02:46Z","timestamp":1789498966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":47,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045364","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-08-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}